Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

University of Leeds to study mechanism of Prana’s PBT434 in animal models of Parkinson’s disease

Prana Biotechnology today announced that Parkinson’s UK has awarded £150,000 (AU$260,000) to The University of Leeds to study the mechanism of action of PBT434.

4 Sep 2013

Salford Royal consultant neurologist to launch largest study of pain in Parkinson's disease

Salford Royal Consultant Neurologist and University of Manchester academic Dr Monty Silverdale is to launch the largest ever study of pain in Parkinson's Disease.

30 Aug 2013

Research team examines link between genetics and memory problems in Parkinson's patients

A research team at University of Virginia School of Medicine led by Matthew Barrett, MD, MSc, will use a state grant to examine the link between genetics and memory problems in Parkinson's disease patients. Barrett hopes the research will eventually lead to customized treatments for Parkinson's disease patients.

30 Aug 2013

Five things every person should know about Parkinson's disease

Michael J. Fox is back in the spotlight this fall in a new sitcom "The Michael J. Fox Show" and spreading awareness about Parkinson's disease, a condition both he and his TV character have in common. Fox has been an outspoken advocate for Parkinson's disease research and awareness since disclosing his condition to the public in 1998.

30 Aug 2013

Study reveals relationship between migraine and low income status

Studies show that migraine is more common among people with lower incomes. This relationship is examined in a study published in the August 28, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology, looking at whether developing migraines limits people's educational and career achievements, leading to a lower income status, or whether problems related to low income such as stressful life events and poor access to health care increase the likelihood of developing migraines.

29 Aug 2013

Study shows that migraine may have long-term effects on the brain's structure

Migraine may have long-lasting effects on the brain's structure, according to a study published in the August 28, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Aug 2013

Reversing inflammation in fluid near brain's cortex may provide solution to Parkinson's disease

Reversing inflammation in the fluid surrounding the brain's cortex may provide a solution to the complex riddle of Parkinson's, according to researchers who have found a link between pro-inflammatory biomarkers and the severity of symptoms such as fatigue, depression and anxiety in patients with the chronic disease.

29 Aug 2013

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Approval for the IMAGINE trial was granted by the Austin Health Research Ethics Committee in November 2011, with the first patients dosed in March the following year. However, well before the trial was approved, PBT2 had already shown promise in significantly changing Abeta levels in spinal fluid while improving cognition in a previous 12-week trial conducted in 2006.

28 Aug 2013

SDSU researchers develop new device to accurately diagnose concussions from sidelines

In the United States there are millions of sports related concussions each year, but many go undiagnosed because for some athletes, the fear of being benched trumps the fear of permanent brain damage, and there is no objective test available to accurately diagnose concussions on the sidelines.

28 Aug 2013

Novel Parkinson’S Target Uncovered

Researchers from Johns Hopkins and the National Cancer Institute (NCI) highlighted a novel mechanism underlying Parkinson's disease while simultaneously putting to rest a previously held theory regarding progression of the disorder. They also identified a compound that alleviates the disease's symptoms in mice.

27 Aug 2013

Scientists finds link between protein phosphorylation and Parkinson's disease

Clues left at the scene of the crime don't always point to the guilty party, as EPFL researchers investigating Parkinson's disease have discovered. It is generally accepted that the disease is aggravated when a specific protein is transformed by an enzyme.

27 Aug 2013

Comprehensive test of biomarkers have prognostic and diagnostic value in Parkinson's disease

Perelman School of Medicine researchers at the University of Pennsylvania report the first biomarker results reported from the Parkinson's Progression Markers Initiative (PPMI), showing that a comprehensive test of protein biomarkers in spinal fluid have prognostic and diagnostic value in early stages of Parkinson's disease.

27 Aug 2013

Scientists identify specific type of receptor that may aid in treatment of AD, Parkinson’s disease

Scientists at Washington University School of Medicine in St. Louis have found a way that corrupted, disease-causing proteins spread in the brain, potentially contributing to Alzheimer's disease, Parkinson's disease and other brain-damaging disorders.

26 Aug 2013

Researchers identify compound that eases symptoms of Parkinson's disease

Researchers at Johns Hopkins and elsewhere have brought new clarity to the picture of what goes awry in the brain during Parkinson's disease and identified a compound that eases the disease's symptoms in mice.

26 Aug 2013

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it has reached agreement with the U.S. Food and Drug Administration for two special protocol assessments for the Company's pivotal Phase 3 program with NAV5001 as an aid in the differential diagnosis of Parkinsonian Syndromes from non-Parkinsonian tremor.

23 Aug 2013

Chronic traumatic encephalopathy may affect people's thinking, memory, behavior and mood

New research suggests that chronic traumatic encephalopathy, a brain disease associated with repeat brain trauma including concussions in athletes, may affect people in two major ways: initially affecting behavior or mood or initially affecting memory and thinking abilities.

22 Aug 2013

Research findings may lead to treatments for disorders triggered by circadian clock dysfunction

Overnight flights across the Atlantic, graveyard shifts, stress-induced insomnia are all prime culprits in keeping us from getting a good night's sleep. Thanks to new research from McGill University and Concordia University, however, these common sleep disturbances may one day be put to bed.

22 Aug 2013

LBDA creates two LBD symptom checklists for physicians and patients

The Lewy Body Dementia Association announced today the launch of new resources for physicians and their patients. LBDA created two new LBD symptom checklists; an abbreviated checklist to assist in the reporting of LBD diagnostic symptoms and a more comprehensive checklist to help people already diagnosed with LBD or their caregivers to report new or concerning LBD symptoms as the disease progresses.

22 Aug 2013

Pilots who fly at high altitudes may be at increased risk for brain lesions

A new study suggests that pilots who fly at high altitudes may be at an increased risk for brain lesions. The study is published in the August 20, 2013, print issue of Neurology, the medical journal of the American Academy of Neurology.

20 Aug 2013

UCSF study shows potential for new treatment strategy for Parkinson’s disease

UC San Francisco scientists working in the lab used a chemical found in an anti-wrinkle cream to prevent the death of nerve cells damaged by mutations that cause an inherited form of Parkinson-s disease.

17 Aug 2013

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

University of Leeds to study mechanism of Prana’s PBT434 in animal models of Parkinson’s disease

Salford Royal consultant neurologist to launch largest study of pain in Parkinson's disease

Research team examines link between genetics and memory problems in Parkinson's patients

Five things every person should know about Parkinson's disease

Study reveals relationship between migraine and low income status

Study shows that migraine may have long-term effects on the brain's structure

Reversing inflammation in fluid near brain's cortex may provide solution to Parkinson's disease

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

SDSU researchers develop new device to accurately diagnose concussions from sidelines

Novel Parkinson’S Target Uncovered

Scientists finds link between protein phosphorylation and Parkinson's disease

Comprehensive test of biomarkers have prognostic and diagnostic value in Parkinson's disease

Scientists identify specific type of receptor that may aid in treatment of AD, Parkinson’s disease

Researchers identify compound that eases symptoms of Parkinson's disease

Navidea Biopharmaceuticals signs SPA agreements with FDA for NAV5001 Phase 3 program

Chronic traumatic encephalopathy may affect people's thinking, memory, behavior and mood

Research findings may lead to treatments for disorders triggered by circadian clock dysfunction

LBDA creates two LBD symptom checklists for physicians and patients

Pilots who fly at high altitudes may be at increased risk for brain lesions

UCSF study shows potential for new treatment strategy for Parkinson’s disease

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in